Cargando…
Pleiotropic Role of HSF1 in Neoplastic Transformation
HSF1 (Heat Shock transcription Factor 1) is the main transcription factor activated in response to proteotoxic stress. Once activated, it induces an expression of heat shock proteins (HSPs) which enables cells to survive in suboptimal conditions. HSF1 could be also activated by altered kinase signal...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435066/ https://www.ncbi.nlm.nih.gov/pubmed/24467529 http://dx.doi.org/10.2174/1568009614666140122155942 |
_version_ | 1782371844128505856 |
---|---|
author | Vydra, Natalia Toma, Agnieszka Widlak, Wieslawa |
author_facet | Vydra, Natalia Toma, Agnieszka Widlak, Wieslawa |
author_sort | Vydra, Natalia |
collection | PubMed |
description | HSF1 (Heat Shock transcription Factor 1) is the main transcription factor activated in response to proteotoxic stress. Once activated, it induces an expression of heat shock proteins (HSPs) which enables cells to survive in suboptimal conditions. HSF1 could be also activated by altered kinase signaling characteristic for cancer cells, which is a probable reason for its high activity found in a broad range of tumors. There is rapidly growing evidence that HSF1 supports tumor initiation and growth, as well as metastasis and angiogenesis. It also modulates the sensitivity of cancer cells to therapy. Functions of HSF1 in cancer are connected with HSPs’ activity, which generally protects cells from apoptosis, but also are independent of its classical targets. HSF1-dependent regulation of non-HSPs genes plays a role in cell cycle progression, glucose metabolism, autophagy and drug efflux. HSF1 affects the key cell-survival and regulatory pathways, including p53, RAS/MAPK, cAMP/PKA, mTOR and insulin signaling. Although the exact mechanism of HSF1 action is still somewhat obscure, HSF1 is becoming an attractive target in anticancer therapies, whose inhibition could enhance the effects of other treatments. |
format | Online Article Text |
id | pubmed-4435066 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Bentham Science Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-44350662015-05-22 Pleiotropic Role of HSF1 in Neoplastic Transformation Vydra, Natalia Toma, Agnieszka Widlak, Wieslawa Curr Cancer Drug Targets Article HSF1 (Heat Shock transcription Factor 1) is the main transcription factor activated in response to proteotoxic stress. Once activated, it induces an expression of heat shock proteins (HSPs) which enables cells to survive in suboptimal conditions. HSF1 could be also activated by altered kinase signaling characteristic for cancer cells, which is a probable reason for its high activity found in a broad range of tumors. There is rapidly growing evidence that HSF1 supports tumor initiation and growth, as well as metastasis and angiogenesis. It also modulates the sensitivity of cancer cells to therapy. Functions of HSF1 in cancer are connected with HSPs’ activity, which generally protects cells from apoptosis, but also are independent of its classical targets. HSF1-dependent regulation of non-HSPs genes plays a role in cell cycle progression, glucose metabolism, autophagy and drug efflux. HSF1 affects the key cell-survival and regulatory pathways, including p53, RAS/MAPK, cAMP/PKA, mTOR and insulin signaling. Although the exact mechanism of HSF1 action is still somewhat obscure, HSF1 is becoming an attractive target in anticancer therapies, whose inhibition could enhance the effects of other treatments. Bentham Science Publishers 2014-02 2014-02 /pmc/articles/PMC4435066/ /pubmed/24467529 http://dx.doi.org/10.2174/1568009614666140122155942 Text en © Bentham Science Publishers http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestrictive use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Article Vydra, Natalia Toma, Agnieszka Widlak, Wieslawa Pleiotropic Role of HSF1 in Neoplastic Transformation |
title | Pleiotropic Role of HSF1 in Neoplastic Transformation |
title_full | Pleiotropic Role of HSF1 in Neoplastic Transformation |
title_fullStr | Pleiotropic Role of HSF1 in Neoplastic Transformation |
title_full_unstemmed | Pleiotropic Role of HSF1 in Neoplastic Transformation |
title_short | Pleiotropic Role of HSF1 in Neoplastic Transformation |
title_sort | pleiotropic role of hsf1 in neoplastic transformation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435066/ https://www.ncbi.nlm.nih.gov/pubmed/24467529 http://dx.doi.org/10.2174/1568009614666140122155942 |
work_keys_str_mv | AT vydranatalia pleiotropicroleofhsf1inneoplastictransformation AT tomaagnieszka pleiotropicroleofhsf1inneoplastictransformation AT widlakwieslawa pleiotropicroleofhsf1inneoplastictransformation |